Wikidata

(Q61907500)

English

Atezolizumab Trial in Endometrial Cancer - AtTEnd

clinical trial

In more languages

Statements

short name
AtTEnd (English)
0 references
title
Phase III Double-blind Randomized Placebo Controlled Trial of Atezolizumab in Combination With Paclitaxel and Carboplatin in Women With Advanced/Recurrent Endometrial Cancer (English)
0 references
country
Austria
0 references
Germany
0 references
Italy
0 references
Spain
0 references
Switzerland
0 references
United Kingdom
0 references
start time
2 October 2018
0 references
end time
July 2021
0 references
number of participants
550
0 references
research intervention
carboplatin
0 references
paclitaxel
0 references
atezolizumab
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61907500&oldid=2105564000"